Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients

Clinical trial NCT05411133 · COMPLETED

Trial details

NCT number: NCT05411133
Sponsor: Arbele Pty Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Cancer Cholangiocarcinoma Liver Cancer Colorectal Adenocarcinoma Pancreatic Cancer Gastric Cancer Esophageal Adenocarcinoma Gastroesophageal Junction Gastrointestinal Neuroendocrine Tumors

Start date: 2022-05-30
Primary completion: 2025-07-23
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.